The 2021 R T Hall Prize winners are Professor Peter Thompson and Professor Mark Nidorf 

Congratulations to the 2021 R T Hall Prize Winners: Professor Peter Thompson and Professor Mark Nidorf 

Professors Thompson and Nidorf have made a significant contribution to cardiovascular medicine in their pursuit of the role of colchicine in preventing coronary events.

In the last 14 years Nidorf and Thompson’s work has propelled the idea of treating atherosclerotic inflammation with colchicine from the bedside into the international spotlight. Not only has it helped to “close the loop” on the inflammatory hypothesis of atherosclerosis, but colchicine’s potential as a cornerstone therapy for secondary prevention coronary disease with an inexpensive readily available drug with an impressive safety profile, is now seriously considered. Work continues to determine if early intolerance to colchicine can be reduced by differing dosing regimens and how best to monitor anti-inflammatory effect in atherosclerosis. The evidence from trials completed to date suggest that repurposing colchicine for secondary prevention of CV disease has the potential to change practice and have a global impact on CV disease. 

Congratulations to Prof Clara Chow and her Quartet team!

Congratulations to Prof Clara Chow and her Quartet Investigators team.

Exciting to see Prof Chow share and present the results of the QUARTET at the 2021 Digital ESC Congress over the weekend and simultaneously released by The Lancet.see link below

Prof Chow said that she was so excited to have delivered it, “…several ups and downs [along the] way.. would love to see it shake it up on how we do things in managing High BP”.

Please feel free to ask Clara Chow any questions via the Discussion Forum on this page.

 

authors.elsevier.com – READ in full on The Lancet here

Congratulations to the CSANZ 2021 Prizewinners

ALLIED HEALTH SCIENCE, TECHNOLOGY PRIZE

Ingrid Stacey, University of WA

Abstract:  Long-term outcomes after RHD diagnosis in Australia: a linked data study.

Judges: Leah Wright, Stephanie Partridge

CARDIOVASCULAR GENETICS PRIZE

Stacey Peters, Royal Melbourne Hospital, VIC

Abstract: Arrhythmias are a Requisite Feature of SCN5A Mediated Dilated Cardiomyopathy : A Systematic Review of Variants

Judges: Jon Skinner, Kathryn Waddell-Smith

CARDIAC IMAGING PRIZE

Siddharth Trivedi, Westmead Hospital, NSW

Speckle tracking echocardiography predicts arrhythmia recurrence in patients with structural heart disease following ventricular tachycardia ablation.

Judges: Sudhir Wahi, Angeline Leet

CARDIOVASCULAR NURSING PRIZE

Lynda Tivendale, Royal Melbourne Hospital, VIC

Multimodal lung and sternal ultrasound education program for cardiothoracic nurses and physiotherapists.

Judges: Robyn Clarke, Jan Cameron, Judith Finn

HEART FAILURE PRIZE

Praveen Indraratna, Prince of Wales Hospital, NSW

TeleClinical Care: A randomised control trial of a smartphone-based model of care for patients with heart failure or acute coronary syndrome.

Judges: Mayanna Lund, Aaron Sverdlov

HEART RHYTHM PRIZE

Varun Malik, Royal Adelaide Hospital, SA

AF begets autonomic nervous system dysfunction: a possible contributor to “AF begets AF”.

Judges: Saurabh Kumar, Martin Stiles

INDIGENEOUS HEALTH PRIZE

Katharine McBride, SAHMRI, SA

When the heart is spiritually and physically strong, women have lower incident cardiovascular disease: Quantifying Aboriginal women’s narrative of cardiovascular protection.

Judges: Judith Katzenellenbogen, William Wang

PAEDIATRIC AND CONGENITAL CARDIOLOGY PRIZE

Karina Laohachai, Women’s and Children’s Hospital, SA

Older age of Fontan completion is associated with impaired lung function.

Judges: Michael Cheung, Mugur Nicolae

PREVENTATIVE CARDIOLOGY PRIZE

Kasun De Silva, Westmead Hospital, NSW

Sex-based differences in implantation of pacemakers, implantable cardioverter defibrillators and cardiac resynchronisation therapy: a 10-year study of 1,291,258 patients in New South Wales.

Judges: Stephen Nicholls, David Colquhoun

Life Membership awarded to Prof Mark Webster

Mark Webster has made an outstanding contribution to CSANZ over four decades. Upon his return to Green Lane Hospital from the Mayo Clinic, he has served on multiple CSANZ Board Committees including the Professional and Ethical Standards Committee (PESC) and the Continuing Education and Recertification Committee (CERC) and he was the Convenor of 2001 CSANZ ASM. Mark has been a member of the NZ Regional Committee Executive for much of the past 25 years, serving as Secretary from 2000-2002.  In 2011, Mark was appointed the NZ-elected CSANZ Board Member.

Mark’s wisdom and leadership are valued by the cardiology community and Society alike. This was reflected when he was voted President-elect of the Society in 2015. During Mark’s tenure as President he forged a closer relationship with the European Society of Cardiology and the American College of Cardiology.  He oversaw financial optimisation of the Annual Scientific Meetings and he lead the Society into areas of accreditation and national registries – he continues as a Board member of the Australasian Cardiac Outcomes Registry (ACOR).

Submitting for NHMRC Clinical Trials & Cohort Studies funding? ANZACT can help

Call for Expressions of Interest to attend the ANZACT Peer Review Workshop on Wednesday 4 August 2021.

Closing Date:  COB Monday 5th July, 2021

If you are planning on submitting for NHMRC Clinical Trials & Cohort Studies funding?  Need help to review before 


Visit the ANZACT website  for more information on their Peer Review Workshops is and other upcoming webinars and events available through our partners at ANZACT.

Selected applicants will:

  • Be an ANZACT member and able to attend the workshop (it’s free to join – Click Here)
  • Work with a Principal Reviewer before the workshop
  • Receive support from senior multidisciplinary ANZACT Committee members at the workshop

See all the latest news from ANZACT including:  reports and resources, other events and webinars, consumers in research and other news

Posts navigation